Orion Portfolio Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.64M | Buy |
9,573
+610
| +7% | +$296K | 0.05% | 367 |
|
|
2024
Q4 | $3.61M | Buy |
8,963
+154
| +2% | +$62K | 0.04% | 428 |
|
|
2024
Q3 | $4.1M | Sell |
8,809
-710
| -7% | -$330K | 0.04% | 399 |
|
|
2024
Q2 | $4.46M | Buy |
9,519
+1,133
| +14% | +$531K | 0.05% | 343 |
|
|
2024
Q1 | $3.51M | Sell |
8,386
-1,623
| -16% | -$678K | 0.04% | 425 |
|
|
2023
Q4 | $4.19M | Sell |
10,009
-485
| -5% | -$203K | 0.05% | 344 |
|
|
2023
Q3 | $3.65M | Sell |
10,494
-1,048
| -9% | -$364K | 0.04% | 379 |
|
|
2023
Q2 | $4.06M | Buy |
11,542
+662
| +6% | +$233K | 0.04% | 374 |
|
|
2023
Q1 | $3.43M | Buy |
10,880
+8,523
| +362% | +$2.69M | 0.04% | 373 |
|
|
2022
Q4 | $681K | Buy |
2,357
+432
| +22% | +$125K | 0.02% | 406 |
|
|
2022
Q3 | $557K | Buy |
1,925
+302
| +19% | +$87.4K | 0.02% | 395 |
|
|
2022
Q2 | $457K | Sell |
1,623
-192
| -11% | -$54.1K | 0.02% | 425 |
|
|
2022
Q1 | $474K | Sell |
1,815
-379
| -17% | -$99K | 0.02% | 443 |
|
|
2021
Q4 | $482K | Buy |
2,194
+20
| +0.9% | +$4.39K | 0.02% | 437 |
|
|
2021
Q3 | $394K | Buy |
+2,174
| New | +$394K | 0.01% | 452 |
|
|
2021
Q2 | – | Sell |
-971
| Closed | -$209K | – | 638 |
|
|
2021
Q1 | $209K | Sell |
971
-377
| -28% | -$81.1K | 0.01% | 518 |
|
|
2020
Q4 | $319K | Sell |
1,348
-166
| -11% | -$39.3K | 0.01% | 382 |
|
|
2020
Q3 | $412K | Buy |
1,514
+342
| +29% | +$93.1K | 0.02% | 298 |
|
|
2020
Q2 | $340K | Buy |
1,172
+251
| +27% | +$72.8K | 0.02% | 300 |
|
|
2020
Q1 | $219K | Buy |
921
+112
| +14% | +$26.6K | 0.02% | 306 |
|
|
2019
Q4 | $177K | Buy |
+809
| New | +$177K | 0.01% | 328 |
|